We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHAC
5426
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$2K ﹤0.01%
+160
New +$1.63K
BHACU
5427
DELISTED
Focus Impact BH3 Acquisition Company Units
BHACU
$2K ﹤0.01%
200
AAGR
5428
DELISTED
African Agriculture Holdings Inc
AAGR
$2K ﹤0.01%
243
-8
-3% -$58
BGXX
5429
DELISTED
Bright Green Corporation Common Stock
BGXX
$2K ﹤0.01%
1,958
-9,269
-83% -$7.42K
KA
5430
DELISTED
Kineta, Inc. Common Stock
KA
$2K ﹤0.01%
+707
New +$4.22K
AACI
5431
DELISTED
Armada Acquisition Corp. I Common Stock
AACI
$2K ﹤0.01%
234
+150
+179% +$1.52K
NEXI
5432
DELISTED
NexImmune, Inc. Common Stock
NEXI
$2K ﹤0.01%
261
BIOL
5433
DELISTED
Biolase, Inc.
BIOL
$2K ﹤0.01%
73
+20
+38% +$973
TDCX
5434
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$2K ﹤0.01%
198
+181
+1,065% +$2.19K
CYAN
5435
DELISTED
Cyanotech Corp
CYAN
$2K ﹤0.01%
1,879
-2,136
-53% -$2.47K
PBAXU
5436
DELISTED
Phoenix Biotech Acquisition Corp. Unit
PBAXU
$2K ﹤0.01%
175
SFE
5437
DELISTED
Safeguard Scientifics, Inc.
SFE
$2K ﹤0.01%
+1,010
New +$2.79K
HCDI
5438
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
$2K ﹤0.01%
561
+518
+1,205% +$4.3K
BSMN
5439
DELISTED
Invesco BulletShares 2023 Municipal Bond ETF
BSMN
$2K ﹤0.01%
+86
New +$2.16K
MIRO
5440
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$2K ﹤0.01%
1,298
-7,726
-86% -$20.1K
SGII
5441
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$2K ﹤0.01%
170
-19
-10% -$195
JGGCU
5442
DELISTED
Jaguar Global Growth Corporation I Unit
JGGCU
$2K ﹤0.01%
203
PYR
5443
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$2K ﹤0.01%
2,662
+812
+44% +$728
UFAB
5444
DELISTED
Unique Fabricating, Inc.
UFAB
$2K ﹤0.01%
9,285
+1
+0%
WGRO
5445
DELISTED
WisdomTree U.S. Growth & Momentum Fund
WGRO
$2K ﹤0.01%
96
HPLT
5446
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
$2K ﹤0.01%
238
+58
+32% +$589
BTWNU
5447
DELISTED
Bridgetown Holdings Limited Units
BTWNU
$2K ﹤0.01%
198
CGRN
5448
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$2K ﹤0.01%
1,728
-4,996
-74% -$8.79K
LFAC
5449
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
$2K ﹤0.01%
163
+31
+23% +$321
EBET
5450
DELISTED
EBET, INC. Common Stock
EBET
$2K ﹤0.01%
136
+103
+312% +$1.73K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.